Doxycycline Use in Adolescent Psychiatric Patients and Risk of Schizophrenia: An Emulated Target Trial
These findings raise the tentative but exciting possibility that doxycycline treatment may reduce schizophrenia risk in adolescent psychiatric patients.
Authors
- Eero Kajantie (ORCID: https://orcid.org/0000-0001-7081-8391)
- Colm Healy (ORCID: https://orcid.org/0000-0001-7974-1861)
- Anna Pulakka (ORCID: https://orcid.org/0000-0002-0602-8632)
- Hugh Ramsay
- Ian Kelleher (ORCID: https://orcid.org/0000-0003-1484-651X)
- K. O’Connor (ORCID: https://orcid.org/0000-0003-0696-8576)
- Fiona Boland (ORCID: https://orcid.org/0000-0003-3228-0046)
- Johanna Metsälä (ORCID: https://orcid.org/0000-0003-3806-1020)
- Ulla Lång (ORCID: https://orcid.org/0000-0002-1399-0635)
- Katriina Heikkilä (ORCID: https://orcid.org/0000-0001-6269-6881)
- Anne Lawlor
- Juha Veijola
Institutions
- University College Dublin (IE)
- Norwegian University of Science and Technology (NO)
- University of Medicine and Health Sciences (KN)
- Health Service Executive (IE)
- Finnish Institute for Health and Welfare (FI)
- 22q11 Ireland (IE)
- St John of God Hospital (AU)
- Early Intervention Foundation (GB)
- University of Oulu (FI)
- University of Edinburgh (GB)
Publication Details
- Journal
- American Journal of Psychiatry
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1176/appi.ajp.20240958
- Citations
- 4
- Primary Topic
- Tryptophan and brain disorders
- Type
- article
- Field-Weighted Citation Impact
- 2.31